September 23, 2008

HELIX BIOPHARMA TO PRESENT L-DOS47 RESEARCH FINDINGS AT THE NATIONAL RESEARCH COUNCIL OF CANADA’S EIGHTH ANNUA L GENERAL MEETING OF THE GENOMICS AND HEALTH INITIATIVE IN SASKATOON, CANADA (PDF)

(Aurora, Ontario) – Helix BioPharma announced today that Dr. Heman Chao, Vice President of Research at Helix BioPharma Corp., will be presenting L-DOS47 research findings at the National Research Council of Canada’s (NRC) Eighth Annual General Meeting of the Genomics and Health Initiative, today in Saskatoon, Saskatchewan, Canada. The meeting includes Canadian researchers from across the NRC, government departments and private industry and covers diverse topics in genomics research